Immuron Ltd IMRN:NASDAQ

RT Quote | USD
Last | 05/16/24 EDT
2.30quote price arrow down-0.01 (-0.43%)
Volume
3,490
52 week range
1.48 - 5.96
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.31
  • 52 Week High5.96
  • 52 Week High Date03/07/24
  • 52 Week Low1.48
  • 52 Week Low Date11/09/23

Key Stats

  • Market Cap13.4M
  • Shares Out227.8M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change23.2

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close2.31
  • 52 Week High5.96
  • 52 Week High Date03/07/24
  • 52 Week Low1.48
  • 52 Week Low Date11/09/23
  • Market Cap13.4M
  • Shares Out227.8M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change23.2

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Immuron Ltd

 

Content From Our Affiliates

Profile

MORE
Immuron Limited is an Australia-based biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. It operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects in Australia, Israel and the United States. The Company's flagship commercial products consist of Travelan and Protectyn. Travelan is an over the...
Paul Brennan
Non-Executive Independent Chairman of the Board
Steven Lydeamore
Chief Executive Officer
Jerry Kanellos Ph.D.
Chief Operating Officer
Phillip Hains
Chief Financial Officer, Company Secretary
Address
L 3 62 Lygon St
Melbourne, VIC
3053
Australia